HeartBeam (BEAT) Cash from Financing Activities (2020 - 2026)
HeartBeam's (BEAT) quarterly Cash from Financing Activities came in at $10.3 million in Q2 2026, up 2183.33% year-over-year from $450000.0 in Q2 2025, and up 578.22% quarter-over-quarter from $1.5 million in Q1 2026.
Analysis
HeartBeam (BEAT) Cash from Financing Activities (2020 - 2026) Analysis & Trends
HeartBeam (BEAT) has reported Cash from Financing Activities for 7 consecutive years, with $10.3 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Cash from Financing Activities rose 2183.33% year-over-year to $10.3 million in Q2 2026; TTM through Jun 2026 was $17.7 million, a 53.99% increase from a year earlier, with the FY2025 full-year figure at $16.6 million, up 1815.82% from the prior year.
- Cash from Financing Activities was $10.3 million for Q2 2026 at HeartBeam, up from $1.5 million in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $24.4 million in Q2 2023 and troughed at $2000.0 in Q2 2022.
- A 5-year average of $3.9 million and a median of $480000.0 in 2023 frame the typical range for Cash from Financing Activities.
- Across the five-year window, Cash from Financing Activities tumbled 99.69% in 2022 and soared 1218550.0% in 2023, its largest moves.
- Over 5 years, Cash from Financing Activities stood at $2000.0 in 2022, then surged by 5450.0% to $111000.0 in 2023, then soared by 585.59% to $761000.0 in 2024, then jumped by 668.2% to $5.8 million in 2025, then surged by 75.76% to $10.3 million in 2026.
- The last three Cash from Financing Activities figures came in at $10.3 million (Q2 2026), $1.5 million (Q1 2026), and $5.8 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | -287.90 Mn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | -343.00 Mn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | -95.00 Mn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | -410.00 Mn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | -300,000.00 |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | -510.00 Mn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | -607.30 Mn |
| 9 | Resmed | 32.94 Bn | 31.47 Bn | 861.22 Mn | -263.16 Mn |
| 10 | HeartBeam | 24.23 Mn | 24.23 Mn | - | 10.28 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.28 Mn |
| Mar 31, 2026 | 1.52 Mn |
| Dec 31, 2025 | 5.85 Mn |
| Sep 30, 2025 | 45,000.00 |
| Jun 30, 2025 | 450,000.00 |
| Mar 31, 2025 | 10.25 Mn |
| Dec 31, 2024 | 761,000.00 |
| Sep 30, 2024 | 21,000.00 |
| Jun 30, 2024 | 84,000.00 |
| Sep 30, 2023 | 111,000.00 |
| Jun 30, 2023 | 24.37 Mn |
| Mar 31, 2023 | 510,000.00 |
| Jun 30, 2022 | 2,000.00 |
| Mar 31, 2022 | 348,000.00 |
| Dec 31, 2021 | 14.84 Mn |
| Sep 30, 2021 | 695,000.00 |
| Jun 30, 2021 | 650,000.00 |
| Mar 31, 2021 | 215,000.00 |
| Dec 31, 2020 | -17,000.00 |